[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-340334-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-340334-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","non-coding-rna-as-a-biomarker-in-lung-cancer","Non-Coding RNA as a Biomarker in Lung Cancer","","Lung cancer continues to cause high global mortality, largely driven by late diagnosis, rapid progression, and frequent recurrence, leaving prognosis poor despite diagnostic and treatment advances. This review synthesizes current evidence that non-coding RNAs, including microRNAs, long non-coding RNAs, and circular RNAs, regulate gene expression and key cancer processes such as initiation, progression, metastasis, and therapy resistance. It assesses their roles as biomarkers for early diagnosis, prognosis, and treatment-response prediction, outlines recent diagnostic and therapeutic strategies, and highlights remaining challenges and future directions.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/non-coding-rna-as-a-biomarker-in-lung-cancer/340334/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/non-coding-rna-as-a-biomarker-in-lung-cancer/340334.png","ImageObject",300,407,{"name":42,"@type":43},"Skyler","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-06","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why are non-coding RNAs considered promising biomarkers for lung cancer?","Question",{"text":63,"@type":64},"Non-coding RNAs regulate gene expression and influence lung cancer initiation, progression, metastasis, and therapy resistance. Their tissue-specific expression patterns and stability in body fluids support non-invasive biomarker use for diagnosis and prognosis.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What types of non-coding RNAs are discussed in the review?",{"text":68,"@type":64},"The review focuses on microRNAs, long non-coding RNAs, and circular RNAs, emphasizing their regulatory roles in cancer biology and clinical relevance for lung cancer.",{"name":70,"@type":61,"acceptedAnswer":71},"What challenges and future directions are highlighted?",{"text":72,"@type":64},"The review emphasizes the need for large-scale validation studies and the development of efficient delivery systems for non-coding RNA-based therapies.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},340334,1790193235,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},2336464648746,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","non-coding  \nRNA  \nReview  \nNon-Coding RNA as a Biomarker in Lung Cancer  \nChahat Suri 1, Shashikant Swarnkar 2, LVKS Bhaskar 3 and Henu Kumar Verma 4,5, *  \nCitation: Suri, C.; Swarnkar, S.; Bhaskar, L.; Verma, H.K. Non-Coding RNA as a Biomarker in Lung Cancer. Non-Coding RNA 2024, 10, 50 .  \n[https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)ncrna10050050  \nAcademic Editors: Daniela Calina, Giuseppe Gattuso and Luca Falzone  \nReceived: 4 September 2024  \nRevised: 20 September 2024  \nAccepted: 24 September 2024  \nPublished: 30 September 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, AB T6G 1Z2, Canada; [csuri@ualberta.ca](csuri@ualberta.ca)  \n2 Department of Biochemistry, C.C.M. Medical College, Bhilai 490020, Chhattisgarh, India; [shashikant_bsp@rediffmail.com](shashikant_bsp@rediffmail.com)  \n3 Department of Zoology, Guru Ghasidas Vishwavidyalaya, Bilaspur 495009, Chhattisgarh, India; [lvksbhaskar@gmail.com](lvksbhaskar@gmail.com)  \n4 Department of Immunopathology, Institute of lungs Health and Immunity, Comprehensive Pnemology Center, Helmholtz Zentrum, Neuherberg, 85764 Munich, Germany  \n5 Lung Health and Immunity, Comprehensive Pneumology Center, Helmholtz Zentrum, Neuherberg,  \n85764 Munich, Germany  \n* Correspondence: henu.verma@yahoo.com or henukumar.verma@helmholtz-munich.de  \nAbstract: Introduction: Lung cancer remains one of the most prevalent and deadly cancers globally, with high mortality rates largely due to late-stage diagnosis, aggressive progression, and frequent recurrence. Despite advancements in diagnostic techniques and therapeutic interventions, the overall prognosis for lung cancer patients continues to be dismal. Method: Emerging research has identified non-coding RNAs (ncRNAs), including microRNAs, long non-coding RNAs, and circular RNAs, as critical regulators of gene expression, significantly influencing cancer biology. These ncRNAs play pivotal roles in various aspects of lung cancer pathogenesis, including tumor initiation, progression, metastasis, and resistance to therapy. Results: We provide a comprehensive analysis of the current understanding of ncRNAs in lung cancer, emphasizing their potential as biomarkers for early diagnosis, prognostication, and the prediction of the therapeutic response. We explore the biological functions of ncRNAs, their involvement in key oncogenic pathways, and the molecular mechanisms by which they modulate gene expression and cellular processes in lung cancer. Furthermore, this review highlights recent advances in ncRNA-based diagnostic tools and therapeutic strategies, such as miRNA mimics and inhibitors, lncRNA-targeted therapies, and circRNA-modulating approaches, offering promising avenues for personalized medicine. Conclusion: Finally, we discuss the challenges and future directions in ncRNA research, including the need for large-scale validation studies and the development of efficient delivery systems for ncRNA-based therapies. This review underscores the potential of ncRNAs to revolutionize lung cancer management by providing novel diagnostic and therapeutic options that could improve patient outcomes.  \nKeywords: non-coding RNA; lung cancer; biomarker; therapeutics; mechanism  \n1. Introduction  \nLung cancer (LC), with its high incidence and mortality rates, poses a significant challenge to global health [1] . LC remains a significant global health concern, with high incidence and mortality rates worldwide. According to the latest estimates from GLOBOCAN 2020, there were approximately 2.2 million new LC cases and 1.8 million lung ","cbCaibutM55TTfhA","https://ap.wps.com/l/cbCaibutM55TTfhA","pdf",1656399,25,"English","# Introduction\n# Non-Coding RNAs as Biomarkers in Lung Cancer\n## Diagnostic and Prognostic Potential\n## Therapeutic Targeting and Mechanisms\n# Challenges and Future Directions","[{\"question\":\"Why are non-coding RNAs considered promising biomarkers for lung cancer?\",\"answer\":\"Non-coding RNAs regulate gene expression and influence lung cancer initiation, progression, metastasis, and therapy resistance. Their tissue-specific expression patterns and stability in body fluids support non-invasive biomarker use for diagnosis and prognosis.\"},{\"question\":\"What types of non-coding RNAs are discussed in the review?\",\"answer\":\"The review focuses on microRNAs, long non-coding RNAs, and circular RNAs, emphasizing their regulatory roles in cancer biology and clinical relevance for lung cancer.\"},{\"question\":\"What challenges and future directions are highlighted?\",\"answer\":\"The review emphasizes the need for large-scale validation studies and the development of efficient delivery systems for non-coding RNA-based therapies.\"}]","Non-Coding RNA as a Biomarker in Lung Cancer | PDF",1790035861,63,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/63427c7800008516293370cc429734e1.webp",983,1390,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ea9d532e488c49a933221d271cc77d63.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3e4edab8431f80f6d0b976500f6100ea.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9efaf7c5ec6c33f83069294e817f9f37.webp",980,1385]